Can Regeneron make 'monoclonal antibodies' a catchphrase? To view this email as a web page,
click here Versiti rolls out antibody tests to screen for COVID-19 vaccine-related blood clots Forget the competition. Sanofi still plans to usher its COVID-19 shot across the finish line Can Regeneron make 'monoclonal antibodies' a catchphrase? New COVID-19 ad campaign gives it a go Physician assistants report COVID-19 furloughs and burnout, but remain optimistic for profession's future Illumina pledges $60M in genomic sequencing expertise to help launch global outbreak-tracking network COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show VA, CDC data suggest low-severity COVID-19 patients will need follow-up care Lonza taps temporary workers from Nestlé in COVID shot production push: report UPDATED Coronavirus tracker: HHS turns to community health centers, local leaders to maintain vaccine momentum Featured Story | By Conor Hale Versiti’s blood tests screen for antibodies that may make typical clot treatments harmful to help healthcare providers choose alternative therapies. read more |
| |
|---|
|
Top Stories By Eric Sagonowsky With a half-dozen COVID-19 vaccines on the market or close to it, one of the world's top vaccine players called it quits after R&D delays and setbacks. But not Sanofi. The company still thinks its shot can help meet global demand. read more By Beth Snyder Bulik Regeneron wants people to know monoclonal antibodies are ready and willing to treat COVID-19—and it's fielding a national ad campaign to tell them. The campaign includes four TV ads targeting U.S. regions where infection rates are highest. read more By Dave Muoio A national survey of more than 20,000 physician assistants outlined work disruptions and COVID-19 specialty changes, yet many respondents said they do not believe the pandemic will have a negative impact on the profession. read more By Andrea Park Amid the havoc wreaked around the world by the COVID-19 pandemic, the race is on to build better protections against future outbreaks. After dipping its toe in these waters with the launch of a pathogen-tracking initiative in Africa, Illumina is now fully diving in with a five-year commitment to a global version. read more By Noah Higgins-Dunn,Fraiser Kansteiner,Eric Sagonowsky New data from the CDC show that the COVID-19 vaccines from Pfizer and Moderna dramatically cut hospitalizations in older adults. Europe is on track to reach herd immunity this summer, BioNTech's CEO said. Plus more. read more By Dave Muoio Clinicians and health systems will likely need to provide additional support to COVID-19 survivors, according to two studies outlining new and persistent care needs among patients who were never hospitalized for their initial infection. read more By Fraiser Kansteiner Nestlé workers are helping fill staffing gaps in Lonza's Swiss vaccine manufacturing operations, Reuters reports. The move comes after the CDMO's partner Moderna blamed projected delivery shortfalls on manufacturing holdups in Europe. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more |
|
